000			01925 a2200553 4500
005			20250516141848.0
264		0	_c20131112
008			201311s 0 0 eng d
022			_a1557-3265
024	7		_a10.1158/1078-0432.CCR-12-1956 _2doi
040			_aNLM _beng _cNLM
100	1		_aAxelson, Michael
245	0	0	_aU.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma. _h[electronic resource]
260			_bClinical cancer research : an official journal of the American Association for Cancer Research _cMay 2013
300			_a2289-93 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnilides _xadverse effects
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCarcinoma, Basal Cell _xdrug therapy
650	0	4	_aDrug Approval
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPyridines _xadverse effects
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
650	0	4	_aYoung Adult
700	1		_aLiu, Ke
700	1		_aJiang, Xiaoping
700	1		_aHe, Kun
700	1		_aWang, Jian
700	1		_aZhao, Hong
700	1		_aKufrin, Dubravka
700	1		_aPalmby, Todd
700	1		_aDong, Zedong
700	1		_aRussell, Anne Marie
700	1		_aMiksinski, Sarah
700	1		_aKeegan, Patricia
700	1		_aPazdur, Richard
773	0		_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 19 _gno. 9 _gp. 2289-93
856	4	0	_uhttps://doi.org/10.1158/1078-0432.CCR-12-1956 _zAvailable from publisher's website
999			_c22601725 _d22601725